Fig. 1.
The ATRT cohort of the EU-RHAB registry. A total of 143 ATRTs were analyzed. In 130 cases, enough DNA was available for SMARCB1 mutation analyses. In 93 tumors (= 186 alleles), enough material was present for analyses by FISH; sequencing and MLPA germline information was obtained in 117 patients. A total of 84 samples could be subclassified by 450k DNA methylation arrays.